Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer Patients

Sponsor
McMaster University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00801476
Collaborator
(none)
44
2
25
22
0.9

Study Details

Study Description

Brief Summary

Young women with breast cancer have an increased breast tissue density and conventional imaging tests such as mammography and breast ultrasound are less sensitive and specific for detecting breast cancer than in older breast cancer patients. Breast MRI is an emerging tool that has been proven to improve the ability to identify breast cancers by determining the extent of disease and also detect multifocal, multicentric and bilateral breast cancers. To date, the role of pre-operative breast MRI is not clearly defined. The investigators are proposing a study to evaluate the impact of preoperative breast MRI on surgical decision-making in breast cancer patients <= 50 years. This may lead to improved characterization of breast cancers in these younger patients that may ultimately result in lower local recurrence rates in the future. The additional information attained through the breast MRI may also guide the use of radiation, chemotherapy and/or hormonal therapy in these patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pre-operative bilateral breast MRI
N/A

Detailed Description

Inclusion Criteria:
  • female aged ≤ 50

  • histologically proven invasive breast cancer

Exclusion Criteria:
  • Is not considered a surgical candidate

  • Has had prior breast cancer surgery or an excisional biopsy of the newly diagnosed lesion

  • Has a contraindication to undergoing breast MRI

  • Has inflammatory breast cancer according to the standard clinical definition

  • Has locally advanced breast cancer according to the standard clinical definition

  • Patient is pregnant

  • Has a psychiatric or addictive disorder that would preclude obtaining informed consent or adherence to the protocol

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
A Prospective Cohort Study to Evaluate the Impact of Preoperative Breast Magnetic Resonance Imaging (MRI) on Surgical Decision-Making in Young Patients With Breast Cancer
Study Start Date :
Apr 1, 2008
Anticipated Primary Completion Date :
Dec 1, 2009
Anticipated Study Completion Date :
May 1, 2010

Outcome Measures

Primary Outcome Measures

  1. Does pre-operative magnetic resonance imaging (MRI) effect surgical management in young women with breast cancer [3 months]

Secondary Outcome Measures

  1. Proportion of patients requiring a second surgery due to positive tumour margins. [3 months]

  2. Incidence of multifocal or multicentric or bilateral breast cancer found on MRI [After surgery]

  3. The correlation between MRI tumour size and the pathologic tumour size after surgery. [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female aged <= 50 years

  • Histological proof of invasive breast cancer via fine needle aspiration or core needle biopsy

  • Premenopausal

Exclusion Criteria:
  • Patient not considered an appropriate surgical candidate; i.e., patient is not well enough to have breast cancer surgery

  • Patient has had prior breast cancer surgery or an excisional biopsy of the newly diagnosed cancer

  • Patient has a contraindication to undergoing breast MRI (i.e., pacemaker, neurodefibrillator, metallic foreign bodies, etc.)

  • Patient has inflammatory breast cancer according to the standard clinical definition. This is a type of breast cancer in which there is evidence of erythema and/or edema. The skin of the breast may also have changes of peau d'orange.

  • Patient has locally advanced breast cancer according to the standard clinical definition.

  • Patient is pregnant

  • Patient has a psychiatric or addictive disorder that would preclude them from obtaining informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Josephs' Healthcare Hamilton Ontario Canada L8N 4A6
2 Juravinski Cancer Centre Hamilton Ontario Canada L8V 5C2

Sponsors and Collaborators

  • McMaster University

Investigators

  • Principal Investigator: Nicole Hodgson, MD, Juravinski Cancer Centre
  • Principal Investigator: Som D Mukherjee, MD, Juravinski Cancer Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00801476
Other Study ID Numbers:
  • MRI REB 07-458
First Posted:
Dec 3, 2008
Last Update Posted:
Nov 18, 2009
Last Verified:
Nov 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2009